Johnny Mahlangu to Factor VIIIa
This is a "connection" page, showing publications Johnny Mahlangu has written about Factor VIIIa.
Connection Strength
0,057
-
FRONTIER1: a partially randomized phase 2 study assessing the safety, pharmacokinetics, and pharmacodynamics of Mim8, a factor VIIIa mimetic. J Thromb Haemost. 2024 Apr; 22(4):990-1000.
Score: 0,057